Evan M. Sloane

2.7k total citations · 1 hit paper
21 papers, 2.3k citations indexed

About

Evan M. Sloane is a scholar working on Physiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Evan M. Sloane has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 11 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Evan M. Sloane's work include Pain Mechanisms and Treatments (15 papers), Nerve injury and regeneration (10 papers) and Peripheral Neuropathies and Disorders (5 papers). Evan M. Sloane is often cited by papers focused on Pain Mechanisms and Treatments (15 papers), Nerve injury and regeneration (10 papers) and Peripheral Neuropathies and Disorders (5 papers). Evan M. Sloane collaborates with scholars based in United States, United Kingdom and Australia. Evan M. Sloane's co-authors include Linda R. Watkins, Erin D. Milligan, Steven F. Maier, Annemarie Ledeboer, Matthew G. Frank, Leslie A. Leinwand, Raymond A. Chavez, Stephen J. Langer, Kirk W. Johnson and David E. Martin and has published in prestigious journals such as Journal of Neuroscience, Pain and Neuroscience.

In The Last Decade

Evan M. Sloane

21 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation

2005 580 citations Annemarie Ledeboer, Evan M. Sloane et al. Pain profile →

Peers

Countries citing papers authored by Evan M. Sloane

Since Specialization

Citations

This map shows the geographic impact of Evan M. Sloane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan M. Sloane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan M. Sloane more than expected).

Fields of papers citing papers by Evan M. Sloane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan M. Sloane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan M. Sloane. The network helps show where Evan M. Sloane may publish in the future.

Co-authorship network of co-authors of Evan M. Sloane

This figure shows the co-authorship network connecting the top 25 collaborators of Evan M. Sloane. A scholar is included among the top collaborators of Evan M. Sloane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan M. Sloane. Evan M. Sloane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats 2015 ·Brain Behavior and Immunity ·Lisa C. Loram, Keith A. Strand, Frederick R. Taylor, Evan M. Sloane, Anne‐Marie van Dam, Jayson Rieger, Steven F. Maier, Linda R. Watkins	14
2	Release of Plasmid DNA-Encoding IL-10 from PLGA Microparticles Facilitates Long-Term Reversal of Neuropathic Pain Following a Single Intrathecal Administration 2010 ·Pharmaceutical Research ·Ryan G. Soderquist, Evan M. Sloane, Lisa C. Loram, Jacqueline A. Harrison, (unknown), (unknown), Luke D. Amer, Courtney S. Young, (unknown), Stephen Poole, Matthew G. Frank, Linda R. Watkins, Erin D. Milligan, Melissa J. Mahoney	77
3	Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders 2010 ·Neuroscience ·Khara M. Ramos, (unknown), (unknown), N.Y. Crysdale, Juliet L. Kroll, Frederick R. Taylor, Jackie Harrison, Evan M. Sloane, Steven F. Maier, Linda R. Watkins	101
4	Enduring Reversal of Neuropathic Pain by a Single Intrathecal Injection of Adenosine 2A Receptor Agonists: A Novel Therapy for Neuropathic Pain 2009 ·Journal of Neuroscience ·Lisa C. Loram, Jacqueline A. Harrison, Evan M. Sloane, Mark R. Hutchinson, Paige W. Sholar, Frederick R. Taylor, Debra Berkelhammer, Benjamen D. Coats, Stephen Poole, Erin D. Milligan, Steven F. Maier, Jayson Rieger, Linda R. Watkins	86
5	Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain 2009 ·Gene Therapy ·Evan M. Sloane, Stephen J. Langer, Brian Jekich, Joseph T. Mahoney, Tudor Hughes, Matthew G. Frank, (unknown), (unknown), Brittany Coats, Jackie Harrison, Dennis M. Klinman, Stephen Poole, Steven F. Maier, Kathia M. Johnson, Raymond A. Chavez, L.R. Watkins, Leslie A. Leinwand, Eleanor Milligan	26
6	Long-term control of neuropathic pain in a non-viral gene therapy paradigm 2009 ·Gene Therapy ·Evan M. Sloane, Ryan G. Soderquist, Steven F. Maier, Melissa J. Mahoney, Linda R. Watkins, Erin D. Milligan	32
7	Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy 2008 ·Brain Behavior and Immunity ·Evan M. Sloane, Annemarie Ledeboer, (unknown), Benjamen D. Coats, Miriam E. van Strien, Steven F. Maier, Kirk W. Johnson, Raymond A. Chavez, Linda R. Watkins, Leslie A. Leinwand, Erin D. Milligan, A.-M. van Dam	89
8	Glia in pathological pain: A role for fractalkine 2008 ·Journal of Neuroimmunology ·Erin D. Milligan, Evan M. Sloane, Linda R. Watkins	97
9	PEGylation of brain‐derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution 2008 ·Journal of Biomedical Materials Research Part A ·Ryan G. Soderquist, Erin D. Milligan, Evan M. Sloane, Jacqueline A. Harrison, (unknown), (unknown), Tudor Hughes, Raymond A. Chavez, Kirk W. Johnson, Linda R. Watkins, Melissa J. Mahoney	41
10	Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain 2006 ·PubMed ·Erin D. Milligan, Ryan G. Soderquist, (unknown), John H. Mahoney, Tudor Hughes, Stephen J. Langer, Evan M. Sloane, Steven F. Maier, Leslie A. Leinwand, Linda R. Watkins, Melissa J. Mahoney	84
11	Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain 2006 ·Pain ·Erin D. Milligan, Evan M. Sloane, Stephen J. Langer, Tudor Hughes, Brian Jekich, Matthew G. Frank, John H. Mahoney, Lindsay H. Levkoff, Steven F. Maier, Pedro E. Cruz, Terence R. Flotte, Kirk W. Johnson, (unknown), Raymond A. Chavez, Leslie A. Leinwand, Linda R. Watkins	143
12	259. Plasmid DNA Encoding the Anti-Inflammatory Cytokine Gene, Interleukin-10 (IL-10) for Chronic Pain Control: Taking Advantage of Nuclear Scaffold/Matrix Attachment Regions 2006 ·Molecular Therapy ·Erin D. Milligan, Stephen J. Langer, Tudor Hughes, Evan M. Sloane, John H. Mahoney, Brian Jekich, Steven F. Maier, Leslie A. Leinwand, Linda R. Watkins	1
13	Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats 2006 ·Brain Behavior and Immunity ·Annemarie Ledeboer, Brian Jekich, Evan M. Sloane, John H. Mahoney, Stephen J. Langer, Erin D. Milligan, David E. Martin, Steven F. Maier, Kirk W. Johnson, Leslie A. Leinwand, Raymond A. Chavez, Linda R. Watkins	263
14	Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization 2005 ·Journal of Pain ·(unknown), Evan M. Sloane, (unknown), Erin D. Milligan, (unknown), Henry C. Marsh, Steven F. Maier, Linda R. Watkins	47
15	Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation breakdown → 2005 ·Pain ·Annemarie Ledeboer, Evan M. Sloane, Erin D. Milligan, Matthew G. Frank, (unknown), Steven F. Maier, Linda R. Watkins	580
16	Controlling pathological pain by adenovirally driven spinal production of the anti‐inflammatory cytokine, interleukin‐10 2005 ·European Journal of Neuroscience ·Erin D. Milligan, Stephen J. Langer, Evan M. Sloane, Lin He, Julie Wieseler‐Frank, Kevin O’Connor, David E. Martin, John Forsayeth, Steven F. Maier, Kirk W. Johnson, Raymond A. Chavez, Leslie A. Leinwand, Linda R. Watkins	185
17	Controlling Neuropathic Pain by Adeno-Associated Virus Driven Production of the Anti-Inflammatory Cytokine, Interleukin-10 2005 ·Molecular Pain ·Erin D. Milligan, Evan M. Sloane, Stephen J. Langer, Pedro E. Cruz, Marucia Chacur, Leah E. Spataro, Julie Wieseler‐Frank, Sayamwong E. Hammack, Steven F. Maier, Terence R. Flotte, John Forsayeth, Leslie A. Leinwand, Raymond A. Chavez, Linda R. Watkins	161
18	Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats 2004 ·Pain ·(unknown), Evan M. Sloane, Erin D. Milligan, Marucia Chacur, David E. Martin, Stephen Poole, Henry C. Marsh, Steven F. Maier, Linda R. Watkins	124
19	Spinal gap junctions: Potential involvement in pain facilitation 2004 ·Journal of Pain ·Leah E. Spataro, Evan M. Sloane, Erin D. Milligan, Julie Wieseler‐Frank, (unknown), Brian Jekich, Ruth M. Barrientos, Steven F. Maier, Linda R. Watkins	133
20	Animal Models of Chronic Pain 2004 ·Journal of Pain ·Evan M. Sloane, Stephen J. Langer, Erin D. Milligan, Julie Wieseler‐Frank, John H. Mahoney, Lindsay H. Levkoff, Pedro E. Cruz, Terence R. Flotte, Leslie A. Leinwand, Steven F. Maier, Linda R. Watkins	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact